Diagnostic performance of serum calprotectin in discriminating active from inactive ulcerative colitis in an outpatient setting. (November 2022)
- Record Type:
- Journal Article
- Title:
- Diagnostic performance of serum calprotectin in discriminating active from inactive ulcerative colitis in an outpatient setting. (November 2022)
- Main Title:
- Diagnostic performance of serum calprotectin in discriminating active from inactive ulcerative colitis in an outpatient setting
- Authors:
- Udegbune, Michael
Sharrod–Cole, Hayley
Townsend, Sarah
Allen, Ben
Brookes, Matthew J
Ford, Clare
Gama, Rousseau - Abstract:
- There are limited and conflicting data on the value of serum calprotectin (sCp) in discriminating active from inactive disease activity in ulcerative colitis (UC). Faecal calprotectin (fCp), sCp, serum C-reactive protein (sCRP) and platelets were compared in patients with UC who had clinically active (n = 29) and clinically inactive (n = 42) disease. Serum calprotectin was measured with Bühlmann ® (BMN sCp) and Immunodiagnostik TM (IDK sCp) assays. Median (interquartile range) fCp was higher in active than inactive disease [1004 (466–1922) versus 151 (55–280) µg/g; p < 0.0001). BMN sCp [4534 (3387–6416) versus 4031 (2401–5414) ng/mL; p = 0.1825], IDK sCp [4531 (2920–6433) versus 3307 (2104–4789) ng/mL; p = 0.1065], sCRP [ 4 (2–8) versus 2 (1–4) mg/L; p = 0.0638) and platelets [269 (233–331) versus 280 (227–325) ×10 −9 /L; p = 0.8055] were similar in active and inactive disease respectively. The area under the receiver operator characteristics curves with 95% confidence limits were 0.85 (0.76–0.94) for fCp, 0.61 (0.47–0.74) for BMN sCp, 0.61 (0.48–0.75) for IDK sCp, 0.69 (0.56–0.81) for sCRP and 0.52 (0.38–0.66) for blood platelets. Faecal calprotectin is the optimum biomarker for discriminating between active and inactive UC. The diagnostic performance of sCp, irrespective of assay, and systemic biomarkers was poor; of these sCRP performed best.
- Is Part Of:
- Annals of clinical biochemistry. Volume 59:Number 6(2022)
- Journal:
- Annals of clinical biochemistry
- Issue:
- Volume 59:Number 6(2022)
- Issue Display:
- Volume 59, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 59
- Issue:
- 6
- Issue Sort Value:
- 2022-0059-0006-0000
- Page Start:
- 404
- Page End:
- 409
- Publication Date:
- 2022-11
- Subjects:
- Serum calprotectin -- faecal calprotectin -- serum C-reactive protein ulcerative colitis
Clinical chemistry -- Periodicals
Clinical biochemistry -- Periodicals
616.075 - Journal URLs:
- http://web.ebscohost.com/ehost/detail?sid=810a7788-77dd-439f-9630-ad7f5b199fd3%40sessionmgr4&vid=1&hid=14&bdata=JnNpdGU9ZWhvc3QtbGl2ZSZzY29wZT1zaXRl#db=mnh&jid=0324055 ↗
http://acb.rsmjournals.com ↗
http://www.usc.edu/hsc/nml/e-resources/info/annclib.html ↗
http://www.uk.sagepub.com/home.nav ↗
http://www.ingentaconnect.com/content/rsm/acb ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1177/00045632221116830 ↗
- Languages:
- English
- ISSNs:
- 0004-5632
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23957.xml